These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2993536)

  • 21. Phase I study of aziridinylbenzoquinone (NSC 182986).
    Bedikian AY; Bodey GP; Burgess MA; Freireich EJ
    Cancer Clin Trials; 1981; 4(4):459-63. PubMed ID: 7318128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and clinical pharmacologic studies of aziridinylbenzoquinone.
    Griffin JP; Newman RA; McCormack JJ; Krakoff IH
    Cancer Treat Rep; 1982 Jun; 66(6):1321-5. PubMed ID: 7083235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An analysis of radiotherapy data from the CNS cancer consortium's randomized prospective trial comparing AZQ to BCNU in the treatment of patients with primary malignant brain tumors. The CNS cancer consortium.
    Halperin EC; Gaspar L; Imperato J; Salter M; Herndon J; Dowling S
    Am J Clin Oncol; 1993 Aug; 16(4):277-83. PubMed ID: 8392285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A phase II study of diaziquone in children with recurrent or progressive primary brain tumors: a report from the Childrens Cancer Study Group.
    Ettinger LJ; Ru N; Krailo M; Ruccione KS; Krivit W; Hammond GD
    J Neurooncol; 1990 Aug; 9(1):69-76. PubMed ID: 2213117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A phase I trial of aziridinylbenzoquinone (NSC 192986) in patients with previously treated acute leukemia.
    Van Echo DA; Schulman P; Budman DR; Ferrari A; Wiernik PH
    Am J Clin Oncol; 1982 Aug; 5(4):405-10. PubMed ID: 7113963
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aziridinylbenzoquinone (AZQ) in advanced breast cancer: a Cancer and Leukemia group B phase II trial.
    Budman DR; Forastiere A; Perloff M; Perry M; Aisner J; Weinberg V; Wood W
    Cancer Treat Rep; 1982 Oct; 66(10):1875-6. PubMed ID: 7127327
    [No Abstract]   [Full Text] [Related]  

  • 27. High dose AZQ in renal cancer. A Southwest Oncology Group phase II study.
    Stephens RL; Kirby R; Crawford ED; Bukowski R; Rivkin SE; O'Bryan RM
    Invest New Drugs; 1986; 4(1):57-9. PubMed ID: 3700042
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase II clinical evaluation of AZQ in renal cell carcinoma.
    Decker DA; Kish J; Al-Sarraf M; Goldfarb S
    Am J Clin Oncol; 1986 Apr; 9(2):126-8. PubMed ID: 3717078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A phase II study of aziridinylbenzoquinone (AZQ) in advanced large bowel carcinoma.
    Rubin J; van Hazel GA; Schutt AJ; Moertel CG; O'Connell MJ
    Am J Clin Oncol; 1982 Oct; 5(5):539-40. PubMed ID: 7180832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase II study of diaziquone in untreated advanced gastric carcinoma. A Southwest Oncology Group Study.
    Pugh RP; Fleming T; Guy JT; Weick JK; Ward JH
    Am J Clin Oncol; 1989 Feb; 12(1):11-3. PubMed ID: 2912017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toxicity of aziridinylbenzoquinone for aerobic and hypoxic cells of a transplanted mouse mammary tumor and interaction of the drug with radiation and adriamycin.
    Tannock I
    Cancer Res; 1983 May; 43(5):2059-62. PubMed ID: 6831436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of metastatic breast cancer with AZQ: a phase II trial.
    Martino S; Ratanatharathorn V; Samal BA; Singhakowinta A; Haas C
    Cancer Invest; 1988; 6(3):289-91. PubMed ID: 3167612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase II diaziquone-based chemotherapy trials in patients with anaplastic supratentorial astrocytic neoplasms.
    Schold SC; Mahaley MS; Vick NA; Friedman HS; Burger PC; DeLong ER; Albright RE; Bullard DE; Khandekar JD; Cairncross JG
    J Clin Oncol; 1987 Mar; 5(3):464-71. PubMed ID: 3029339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase II trial of aziridinylbenzoquinone (AZQ) in head and neck cancer.
    Forastiere AA; Crain SM; Callahan K; Van Echo D; Mattox D; Thant M; Von Hoff DD; Wiernik PH
    Cancer Treat Rep; 1982 Dec; 66(12):2097-8. PubMed ID: 6892491
    [No Abstract]   [Full Text] [Related]  

  • 35. Phase I study of diaziquone.
    Frytak S; Eagan RT; Ames MM; Creagan ET; Nichols WC
    Cancer Treat Rep; 1984; 68(7-8):975-8. PubMed ID: 6744349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase II study of irinotecan (CPT-11) in children with high-risk malignant brain tumors: the Duke experience.
    Turner CD; Gururangan S; Eastwood J; Bottom K; Watral M; Beason R; McLendon RE; Friedman AH; Tourt-Uhlig S; Miller LL; Friedman HS
    Neuro Oncol; 2002 Apr; 4(2):102-8. PubMed ID: 11916501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A phase II trial of diaziquone in patients with head and neck cancer.
    Muñiz F; Vélez-García E; Neidhart JA; Bender JF; Becker M; Grillo-Lopez AJ
    Cancer Chemother Pharmacol; 1987; 19(3):265-8. PubMed ID: 3581421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase II clinical evaluation of AZQ in adenocarcinoma of the lung.
    Decker DA; Samson MK; Haas CD; Baker LH
    Am J Clin Oncol; 1984 Aug; 7(4):353-5. PubMed ID: 6741865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A phase II clinical trial of diaziquone in the treatment of patients with recurrent endometrial carcinoma. A Gynecologic Oncology Group study.
    Slayton RE; Blessing JA; DiSaia PJ; Phillips G
    Am J Clin Oncol; 1988 Dec; 11(6):612-3. PubMed ID: 3055931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase I trial and pharmacokinetics of aziridinylbenzoquinone (NSC 182986) in humans.
    Schilsky RL; Kelley JA; Ihde DC; Howser DM; Cordes RS; Young RC
    Cancer Res; 1982 Apr; 42(4):1582-6. PubMed ID: 7060028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.